Daniel J. Gennevois

Daniel J. Gennevois

69 year
Health Technology
Consumer Services

Profile

Daniel J.
Gennevois
has been Vice President of Medical Affairs for Anesiva, Inc. since August 2003.
Previously, he was Senior Managing Director of Xoma Corporation from June 2003 to July 2003, Executive Director and Vice President of Clinical Operations for Dynavax Technologies from June 2001 to June 2003, Senior Director of Clinical Research for Roche Bioscience from March 1997 to May 2001, Director of Clinical Research for Chiron Vaccines from November 1995 to March 1997 and Director of Medical Research for Syntex Corporation from June 1991 to November 1995.
From 1985 to 1991, Dr. Gennevois was Associate Director of Clinical and Business Development for American Bioproducts Co. and Scientific Manager for Porton Products.
He received a Bachelor's degree in Mathematics from Lycee Ampere and a Doctor of Medicine degree from the University of Lyon and completed Clinical Training in Infectious Disease at the Hospital Edouard Herriot.

Former positions of Daniel J. Gennevois

CompaniesPositionEnd
XOMA CORPORATION Chief Tech/Sci/R&D Officer 2006-06-30
DYNAVAX TECHNOLOGIES CORPORATION Chief Tech/Sci/R&D Officer 2003-05-31
Chief Tech/Sci/R&D Officer 2001-04-30
Chief Tech/Sci/R&D Officer 1997-02-28
Syntex Corp. Chief Tech/Sci/R&D Officer 1995-10-31
See the detail of Daniel J. Gennevois's experience

Training of Daniel J. Gennevois

University of Lyon Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Daniel J. Gennevois's experience

Connections

48

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
XOMA CORPORATION

Health Technology

DYNAVAX TECHNOLOGIES CORPORATION

Health Technology

Private companies4

Health Technology

Health Technology

Health Technology

Syntex Corp.

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Daniel J. Gennevois
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW